Table 3.
Cranial radiation therapy (CRT) for CNS3 patients.
| # | Regimen | Gender (F/M) | CRT given (Y/N) | Phase CRT given | Relapse (Y/N) |
|---|---|---|---|---|---|
| 1 | C-MTX | F | N | (refused) | Y |
| 2 | C-MTX | F | Y | Consolidation | Y |
| 3 | C-MTX | M | Y | Consolidation | N |
| 4 | C-MTX | M | Y | Consolidation | N |
| 5 | C-MTX | M | Y | Consolidation | N |
| 6 | HDMTX | M | Y | DI-2 | N |
| 7 | HDMTX | M | N | (relapse)* | Y |
| 8 | HDMTX | M | Y | DI-2 | N |
| 9 | HDMTX | M | N | (relapse)* | Y |
| 10 | HDMTX | M | Y | DI-2 | N |
| 11 | HDMTX | M | Y | DI-2 | N |
| 12 | HDMTX | M | Y | DI-2 | N |
| 13 | HDMTX | M | Y | DI-2 | N |
| 14 | HDMTX | F | N | (relapse)* | Y |
| 15 | HDTMX | M | Y | DI-2 | N |
F = female, M = male.
Y = Yes, N = No.
DI-2 = delayed intensification-2.
⁎
Relapse before planned cranial radiation (CRT) given.